Recombinant varicella zoster virus vaccine

A technology for varicella zoster and virus vaccine, applied in the directions of viruses, viral peptides, antiviral agents, etc., can solve the problem of low purity of expression products, and achieve the effects of large molecular weight, maintaining spatial structure, and strong immunogenicity

Active Publication Date: 2021-06-01
BEIJING LUZHU BIOTECH +1
View PDF5 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above results show that they have achieved the expression of VZV gE in animal cells, but the purity of the obtained expression product is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant varicella zoster virus vaccine
  • Recombinant varicella zoster virus vaccine
  • Recombinant varicella zoster virus vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Embodiment 1, the construction of plasmid expression vector:

[0066] 1. Gene sequence source

[0067] Varicella zoster virus E protein (VZV gE) of the present invention is the extracellular domain (ECD, 31-546aa) of gE protein, totally 516 amino acids; sequence 1). The varicella-zoster virus E protein gene and the human IgG1 Fc gene were concatenated (Appendix: DNA Sequence 2), and Nanjing GenScript Biotechnology Co., Ltd. was commissioned to synthesize the VZV gE-Fc fusion protein gene sequence and connect it to pUC57-1.8 On the K vector, the synthesized gene includes restriction site, Kozak sequence, signal peptide, target gene (2244bp) and stop codon, with a total length of 2355bp. Codon optimization was carried out when the recombinant gene was synthesized to facilitate expression in Chinese hamster ovary cell Cricetulus griseus (CHO cell).

[0068] 2. Construction of expression plasmid containing VZV gE-Fc gene

[0069] Inoculate the glycerol bacteria strain c...

Embodiment 2

[0076] Embodiment 2, establishment and screening of stable clones

[0077]In the sterile laminar flow workbench, set the perforation voltage of the gene pulse generator Xcell (Bio-Rad) to 300V voltage, 900μF single pulse, and infinite resistance, and take out the disposable electric shock cup (Bio-Rad) with a gap of 4mm. Add 40μg linearized plasmid DNA (100μl) and 0.7ml CHO K1 cell suspension (1.5×10 7 cells / ml), the linearized plasmid VZV gE-Fc- was directly transfected into CHO K1 cells by electrotransfection, the cells in the electric shock cup were transferred to the Erlenmeyer flask, and 30ml CD CHO culture medium was added (GIBCO), at 36~37℃, 5%CO 2 Culture on a shaker at 135 rpm. After 24 hours of culture, collect the cells by low-speed centrifugation, replace with CD CHO medium (without glutamine) containing 50 μM MSX, and transfer the cells to a 96-well flat-bottom culture plate by limiting dilution Inside, place the culture plate at 37°C, 10% CO 2 Cultivate in an ...

Embodiment 3

[0078] Embodiment 3, expression and purification of target product

[0079] Inoculate the obtained 5B3 clone into a 2L Erlenmeyer flask containing 500ml of CD CHO culture medium, tighten the cap of the ventilated bottle, and store at 36-37°C, 5% CO 2 , 135r / min on a rotary shaker, after 4 days of culture, transfer 5B3 cells to a 5L automatic bioreactor containing 2.0L CD Opti-CHO culture medium, and set the culture parameters at 60r / min , temperature 36.5°C, pH7.0~pH7.4, dissolved oxygen DO 40%~60%, daily sampling to detect cell viability, cell density, glucose content, after 4 days of culture, the density of viable cells rose to 5×10 6 ~7×10 6 cells / ml, add 200ml~300ml CDEfficient Feed C, and then add it once every other day, measure the glucose content in the culture medium every day, if the glucose content is lower than 11.1mmole / L, add 40% glucose solution through a peristaltic pump Put it into a fully automatic bioreactor until the glucose content reaches 22mmole / L; cul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a recombinant varicella zoster virus vaccine, which comprises an amino acid sequence of a recombinant glycoprotein gE extracellular region of a live attenuated VZV strain (OKA strain) gene and a fusion protein formed by a human immunoglobulin Fc segment, and further comprises preparation and an application of the fusion protein, and a corresponding recombinant gene, an eukaryotic expression vector and the like. The fusion protein provided by the invention has good immunogenicity, and can induce generation of a high-level serum neutralizing antibody.

Description

technical field [0001] The invention relates to a vaccine preparation, which is specially designed to induce the body's immune system to produce neutralizing antibodies against recombinant varicella-zoster virus glycoprotein E fusion protein. Background technique [0002] Varicella-zoster virus (VZV) is a member of the α-herpesvirus subfamily of the genus Herpesviridae. It is a double-stranded DNA virus with a diameter of 150-200 nm. Morphologically, it is composed of nucleic acid core, protein Concentric circular structure composed of capsid and envelope. The VZV genome is a linear double-stranded DNA molecule of about 125kb, including a unique long fragment (UL) of about 100kb and a unique short fragment (US) of about 5.4kb, which are separated by 6.8kb terminal and internal repeat sequences, with a total of 72 Open reading frames (ORF), in addition to encoding protein molecules related to biological activities such as virus replication, transcription, packaging, release,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/25A61K39/39A61K39/385A61P31/22C12N15/62
CPCA61K39/12A61K39/39A61K39/385A61P31/22C07K14/005C07K2319/30C12N2710/16722C12N2710/16734A61K2039/6056A61K2039/55505C07K2319/40Y02A50/30A61K39/25A61K31/22C07K14/525C12N15/62A61K38/385A61K9/19A61K47/02A61K9/0019C12N15/63A61K2039/6031A61K2039/54A61K2039/5254A61K2039/545
Inventor 孔健姜培红彭玲杨帅许磊涛张琨
Owner BEIJING LUZHU BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap